April 17 (Reuters) - Knight Therapeutics Inc:
* KNIGHT THERAPEUTICS ANNOUNCES APPROVAL OF IBSRELA™ IN CANADA
* KNIGHT THERAPEUTICS - HEALTH CANADA APPROVED IBSRELA FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN ADULTS Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.